Free Trial

Russell Low Sells 1,244 Shares of Axcelis Technologies (NASDAQ:ACLS) Stock

Axcelis Technologies logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • CEO Russell Low sold 1,244 shares at an average price of $94.06 (totaling $117,010.64) under a pre-arranged Rule 10b5-1 plan, reducing his holdings to 132,282 shares (a 0.93% drop) per an SEC filing.
  • Recent quarter beat estimates: Axcelis reported $1.49 EPS vs. $1.12 expected and revenue of $238.33M vs. $215.04M, though revenue was down 5.6% year-over-year and the company set Q1 2026 EPS guidance at 0.71.
  • Shares traded down 0.4% to $95.09; the company has a market cap of $2.92B and a P/E of 25.09, about 90% institutional ownership, and analysts' consensus is a Hold with an average target of $101.50.
  • Five stocks to consider instead of Axcelis Technologies.

Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) CEO Russell Low sold 1,244 shares of the firm's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $94.06, for a total value of $117,010.64. Following the transaction, the chief executive officer directly owned 132,282 shares of the company's stock, valued at approximately $12,442,444.92. This represents a 0.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Axcelis Technologies Trading Down 0.4%

ACLS traded down $0.42 during midday trading on Thursday, hitting $95.09. 353,629 shares of the company were exchanged, compared to its average volume of 803,494. The firm's 50 day moving average price is $87.80 and its 200-day moving average price is $86.94. Axcelis Technologies, Inc. has a 1-year low of $40.40 and a 1-year high of $102.93. The firm has a market capitalization of $2.92 billion, a P/E ratio of 25.09, a P/E/G ratio of 11.13 and a beta of 1.65. The company has a quick ratio of 3.11, a current ratio of 4.77 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The semiconductor company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.37. Axcelis Technologies had a return on equity of 13.73% and a net margin of 14.33%.The company had revenue of $238.33 million during the quarter, compared to analysts' expectations of $215.04 million. During the same quarter in the prior year, the firm posted $1.54 earnings per share. The business's quarterly revenue was down 5.6% on a year-over-year basis. Axcelis Technologies has set its Q1 2026 guidance at 0.710-0.710 EPS. As a group, equities analysts forecast that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ACLS. Bank of America raised their price target on shares of Axcelis Technologies from $90.00 to $100.00 and gave the stock an "underperform" rating in a report on Tuesday, January 13th. B. Riley Financial reduced their price objective on shares of Axcelis Technologies from $94.00 to $91.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 18th. Zacks Research cut shares of Axcelis Technologies from a "hold" rating to a "strong sell" rating in a research report on Friday, February 20th. Wall Street Zen lowered shares of Axcelis Technologies from a "buy" rating to a "hold" rating in a report on Saturday, January 3rd. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Axcelis Technologies in a research report on Monday, December 22nd. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $101.50.

View Our Latest Stock Analysis on Axcelis Technologies

Institutional Investors Weigh In On Axcelis Technologies

A number of hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its holdings in shares of Axcelis Technologies by 3.8% during the 1st quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company's stock worth $5,838,000 after buying an additional 4,324 shares in the last quarter. AQR Capital Management LLC increased its stake in shares of Axcelis Technologies by 4.9% in the 1st quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company's stock valued at $1,774,000 after acquiring an additional 1,678 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Axcelis Technologies by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company's stock valued at $963,000 after acquiring an additional 849 shares during the period. Goldman Sachs Group Inc. boosted its stake in Axcelis Technologies by 7.5% during the first quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company's stock worth $31,560,000 after acquiring an additional 44,275 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Axcelis Technologies by 1.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company's stock worth $3,912,000 after acquiring an additional 836 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Company Profile

(Get Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company's product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Axcelis Technologies Right Now?

Before you consider Axcelis Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.

While Axcelis Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines